31/08/2023  21:59:59 Chg. -0.9100 Volume Bid01:50:00 Demandez à01:50:00 Capitalisation boursière Dividende Y. Rapport P/E
39.7500USD -2.24% 31.37 Mio.
Chiffrre d'affaires: 336.35 Mio.
39.2900Bid taille: - 39.9000Ask la taille: - 2.08 Mrd.USD - 50.96

Description de l'entreprise

NuVasive is a global medical device company focused on transforming spine surgery by empowering surgeons with technology to approach procedures in the least disruptive way possible and restore the vitality of life for those that suffer from debilitating spinal conditions. Through its minimally invasive, procedurally-integrated solutions, the Company is expanding the boundaries of modern healthcare with technologies and surgeon training designed to provide reproducible and clinically-proven surgical outcomes that are redefining the success factors of spine surgery like never before. Addressing a variety of pathologies up and down the spine, from complex spinal deformity to degenerative spinal conditions, NuVasive's highly differentiated solutions include access instruments, implantable hardware and increasingly expert software systems like its game-changing iGA™ surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. NuVasive believes its integrated approach and expertise can fundamentally evolve spine care by delivering improved patient experiences, and better economics for healthcare systems.
 

Conseil d'administration & Conseil de surveillance

PDG
J. Christopher Barry
Conseil d'administration
Matthew K. Harbaugh, Aviva McPherron, Brent Boucher, Dale Wolf, Kyle Malone, Lucas Vitale, Massimo Calafiore, Michael Farrington, Nathaniel Sisitsky, Sean Freeman
Conseil de surveillance
Daniel J. Wolterman, Amy Belt Raimundo, Donald J. Rosenberg, J. Christopher Barry, John A. DeFord, Leslie V. Norwalk, R. Scott Huennekens, Robert F. Friel, Siddhartha Kadia, Vickie L. Capps
 

Données de l'entreprise

Nom: NuVasive Inc.
Adresse: 7475 Lusk Boulevard,San Diego, California 92121, USA
Téléphone: +1-858-909-1800
Fax: +1-800-475-9134
Courriel: info@nuvasive.com
Internet: www.nuvasive.com/
Industrie: Healthcare
Secteur: Medical Products
Sous-secteur: Advanced Medical Devices
Fin de l'exercice financier: 31/12
Flotte libre: 60.20%
IPO date: -

Relations avec les investisseurs

Nom: Juliet C. Cunningham
Téléphone IR: +1-858-458-2240
IR-Fax: -
E-mail IR: investorrelations@nuvasive.com

Principaux actionnaires

Freefloat
 
60.20%
Wellington Management Company LLP
 
13.00%
BlackRock, Inc.
 
12.20%
The Vanguard Group
 
9.40%
The Hartford Mutual Funds, Inc.
 
5.20%